Quick Search

 

 


 

 

Filter list by

Home > Result Summaries: Compounds > Combined Diphtheria, Tetanus, Whole Cell Pertussis, Hepatitis B, Haemophilus influenzae Type b Vacci

Result Summaries: Combined Diphtheria, Tetanus, Whole Cell Pertussis, Hepatitis B, Haemophilus influenzae Type b Vacci

GSK
Study ID		    Phase    Title Summary (Download)
101223 phase 3 Study to assess the lot-to-lot consistency of the production method of GSK Bios’ DTPw-HBV/ Hib Kft. vaccine and to compare to GSK Bios’ Tritanrix™-HepB/Hiberix™ vaccine, when admind as a primary vaccination course (0 citation(s)) Click here to download result summary.
104065 phase 3 Immune memory of GSK's DTPw-HBV/Hib vaccine by giving Plain PRP polysaccharide at 10 mths. Immuno & reacto of a booster dose of DTPw-HBV/Hib or DTPw-HBV or DTPw-HBV+Hib at 15-18 mths in infants previously primed with DTPw-HBV/Hib (2 citation(s)) Click here to download result summary.
104727 (Booster - 15-24 mths) phase 3 Assess immunogenicity, safety & reactogenicity of a 4th dose of GSK Biologicals’ Tritanrix™-HepB/Hib-MenAC at 15-24 m & of a dose of Mencevax™ ACWY at 24-30 m in subjects primed with 3 doses of Tritanrix™-HepB/Hib-MenAC (0 citation(s)) Click here to download result summary.
104977 phase 3 Non-inferiority of one formulation of GSK Biologicals' DTPw-HBV/Hib to 2 formulations of GSK Biologicals' DTPw-HBV/Hib with respect to the immune response to the PRP antigen, when administered to healthy infants at 6, 10, 14 weeks of age (1 citation(s)) Click here to download result summary.
106602 phase 3 Immunogenicity, Reactogenicity & Safety of a Booster Dose of GSK Biologicals DTPw-HBV/Hib Kft Vaccine Vs GSK Biologicals DTPw-HBV/Hib Vaccine, in Infants Who Received a 3-Dose Primary Vaccination Course With the Same Vaccines. (1 citation(s)) Click here to download result summary.
113264 phase 2 Immunogenicity and reactogenicity of a booster dose of GlaxoSmithKline Biologicals’ GSK2036874A vaccine in healthy toddlers (2 citation(s)) Click here to download result summary.
213501/018_2 phase 3 Study to evaluate immunogenicity, safety and reactogenicity of two different immunization regimens against hepatitis B, diphtheria, tetanus, pertussis and Haemophilus influenzae type b (Hib)diseases in healthy infants primed with a birth dose of GSK Bio’s hepatitis B (4 citation(s)) Click here to download result summary.